CranioSense is bringing intracranial hypertension into the light by simplifying the diagnostic process across the clinical spectrum.
CranioSense has raised $5.5M in total funding. The most recent round was Grant. The last funding was announced in December 2025.
CranioSense's investors include U.S. Department of War, MassChallenge, MedTech Innovator, Blueprint MedTech.
CranioSense is headquartered in Bedford, United States.
CranioSense is bringing intracranial hypertension into the light by simplifying the diagnostic process across the clinical spectrum.
CranioSense is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CranioSense — Funding & Investors." VCBacked, December 17, 2025, https://www.vcbacked.co/company/craniosense. Accessed October 30, 2026.
VCBacked. (2025). CranioSense — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/craniosense
{{cite web |title=CranioSense — Funding & Investors |url=https://www.vcbacked.co/company/craniosense |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated